KLSE:HARTA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Hartalega Holdings Berhad

Market Cap

RM24.1b

Last Updated

2021/08/01 11:03 UTC

Data Sources

Company Financials +

Executive Summary

Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, North America, Europe, rest of Asia, Australia, South America, the Middle East, Russia, and Africa. More Details


Snowflake Analysis

Flawless balance sheet with outstanding track record and pays a dividend.


Similar Companies

Share Price & News

How has Hartalega Holdings Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HARTA is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: HARTA's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

-8.6%

HARTA

-6.3%

MY Medical Equipment

-1.9%

MY Market


1 Year Return

-65.3%

HARTA

-60.3%

MY Medical Equipment

-1.5%

MY Market

Return vs Industry: HARTA underperformed the MY Medical Equipment industry which returned -60.3% over the past year.

Return vs Market: HARTA underperformed the MY Market which returned -1.5% over the past year.


Shareholder returns

HARTAIndustryMarket
7 Day-8.6%-6.3%-1.9%
30 Day0.3%-0.5%-1.3%
90 Day-29.5%-31.9%-6.6%
1 Year-64.2%-65.3%-57.5%-60.3%2.1%-1.5%
3 Year21.0%14.5%89.1%73.0%-3.6%-12.7%
5 Year269.8%239.3%339.0%286.5%8.7%-9.6%

Long-Term Price Volatility Vs. Market

How volatile is Hartalega Holdings Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Hartalega Holdings Berhad undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: HARTA (MYR7.04) is trading below our estimate of fair value (MYR31.75)

Significantly Below Fair Value: HARTA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: HARTA is poor value based on its PE Ratio (8.3x) compared to the MY Medical Equipment industry average (3.8x).

PE vs Market: HARTA is good value based on its PE Ratio (8.3x) compared to the MY market (17.3x).


Price to Earnings Growth Ratio

PEG Ratio: HARTA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: HARTA is overvalued based on its PB Ratio (4.8x) compared to the MY Medical Equipment industry average (2.6x).


Future Growth

How is Hartalega Holdings Berhad forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

-24.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HARTA's earnings are forecast to decline over the next 3 years (-24.8% per year).

Earnings vs Market: HARTA's earnings are forecast to decline over the next 3 years (-24.8% per year).

High Growth Earnings: HARTA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: HARTA's revenue is expected to decline over the next 3 years (-6.7% per year).

High Growth Revenue: HARTA's revenue is forecast to decline over the next 3 years (-6.7% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HARTA's Return on Equity is forecast to be low in 3 years time (17.1%).


Past Performance

How has Hartalega Holdings Berhad performed over the past 5 years?

43.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HARTA has high quality earnings.

Growing Profit Margin: HARTA's current net profit margins (43.1%) are higher than last year (14.8%).


Past Earnings Growth Analysis

Earnings Trend: HARTA's earnings have grown significantly by 43.4% per year over the past 5 years.

Accelerating Growth: HARTA's earnings growth over the past year (565.4%) exceeds its 5-year average (43.4% per year).

Earnings vs Industry: HARTA earnings growth over the past year (565.4%) exceeded the Medical Equipment industry 41.4%.


Return on Equity

High ROE: HARTA's Return on Equity (58.1%) is considered outstanding.


Financial Health

How is Hartalega Holdings Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: HARTA's short term assets (MYR4.4B) exceed its short term liabilities (MYR1.4B).

Long Term Liabilities: HARTA's short term assets (MYR4.4B) exceed its long term liabilities (MYR439.6M).


Debt to Equity History and Analysis

Debt Level: HARTA's debt to equity ratio (6.9%) is considered satisfactory.

Reducing Debt: HARTA's debt to equity ratio has reduced from 16.5% to 6.9% over the past 5 years.

Debt Coverage: HARTA's debt is well covered by operating cash flow (900.1%).

Interest Coverage: HARTA's interest payments on its debt are well covered by EBIT (584.8x coverage).


Balance Sheet


Dividend

What is Hartalega Holdings Berhad current dividend yield, its reliability and sustainability?

7.24%

Current Dividend Yield


Upcoming Dividend Payment

TodayAug 01 2021Ex Dividend DateSep 23 2021Dividend Pay DateOct 08 202115 days from Ex DividendBuy in the next 52 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: HARTA's dividend (7.24%) is higher than the bottom 25% of dividend payers in the MY market (1.51%).

High Dividend: HARTA's dividend (7.24%) is in the top 25% of dividend payers in the MY market (4.17%)


Stability and Growth of Payments

Stable Dividend: HARTA's dividends per share have been stable in the past 10 years.

Growing Dividend: HARTA's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (46.1%), HARTA's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: HARTA's dividends in 3 years are forecast to be covered by earnings (66.1% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Mun Kuan (45 yo)

8.67yrs

Tenure

RM120,000

Compensation

Mr. Mun Leong Kuan has been a Chief Executive Officer of Hartalega Holdings Berhad since May 18, 2020 and has been its Managing Director since November 16, 2012. Mr. Kuan served as Deputy Managing Director...


Leadership Team

Experienced Management: HARTA's management team is considered experienced (2.6 years average tenure).


Board Members

Experienced Board: HARTA's board of directors are considered experienced (8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Hartalega Holdings Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Hartalega Holdings Berhad
  • Ticker: HARTA
  • Exchange: KLSE
  • Founded: 1988
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: RM24.059b
  • Shares outstanding: 3.42b
  • Website: https://www.hartalega.com.my

Number of Employees


Location

  • Hartalega Holdings Berhad
  • C-G-9, Jalan Dataran SD1
  • Dataran SD, PJU 9
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 52200
  • Malaysia

Listings


Biography

Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, North America, Europe, rest of Asia, Australia, South Am...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/01 11:03
End of Day Share Price2021/07/30 00:00
Earnings2021/03/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.